PVL is a well characterised S. aureus toxin, toxic to the myeloid cells that form a first line of defence against bacterial infection, (Oliveira et al., 2018) and, in binding to myeloid cells by a complement receptor (C5aR), exerts immunomodulatory effects (Spaan et al., 2013). This evidence concerns the gene C5AR1 and bacterial infectious disease.